Professor of Urology Sapienza University of Rome, Italy
Learning Objectives :
At the end of this session, attendees should be able to:
Identify and differentiate ablative and non-ablative MISTs for BPH - Participants will be able to classify minimally invasive techniques based on their mechanism of action and understand their indications, benefits, and limitations.
Select appropriate MISTs based on prostate size and anatomical variations - P
articipants will be able to choose the most suitable minimally invasive treatment for patients with small (<40 cc), medium (40–80 cc), and large (>80 cc) prostates, including strategies for managing median lobe involvement.
Evaluate the impact of MISTs on sexual function and quality of life - Attendees will be able to discuss expected sexual outcomes and patient-reported benefits of different MISTs, integrating this knowledge into shared decision-making.
Presentations:
14:00 - 14:05 GMT+0
Welcome and Introductions
14:00 - 14:15 GMT+0
Pathophysiological rationale behind ablative and non-ablative options
Speaker: Cosimo De Nunzio – Sapienza University of Rome
14:15 - 14:30 GMT+0
Optimal MIST Selection for Small Prostates (<40 cc)
14:30 - 14:45 GMT+0
What MISTs to choose for medium BPH (40-80cc)
14:45 - 15:00 GMT+0
Pushing the boundaries of MISTs: Options for giant adenomas (>80cc)?
15:00 - 15:10 GMT+0
Sexual outcomes after MISTs
Speaker: Nicola Mondaini – Magna Graecia University of Catanzaro Italy
